BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 21802993)

  • 1. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].
    Iranzo A; Lomeña F; Stockner H; Valldeoriola F; Vilaseca I; Salamero M; Molinuevo JL; Serradell M; Duch J; Pavía J; Gallego J; Seppi K; Högl B; Tolosa E; Poewe W; Santamaria J;
    Lancet Neurol; 2010 Nov; 9(11):1070-7. PubMed ID: 20846908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
    Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
    Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Striatal dopamine transporter levels in patients with REM sleep behavior disorder: assessment with 123I-FP-CIT SPECT].
    Mossa EP; Niccoli Asabella A; Iuele F; Stabile Ianora AA; Giganti M; Rubini G
    Recenti Prog Med; 2012 Nov; 103(11):500-4. PubMed ID: 23096739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
    Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder.
    Iranzo A; Santamaría J; Valldeoriola F; Serradell M; Salamero M; Gaig C; Niñerola-Baizán A; Sánchez-Valle R; Lladó A; De Marzi R; Stefani A; Seppi K; Pavia J; Högl B; Poewe W; Tolosa E; Lomeña F
    Ann Neurol; 2017 Sep; 82(3):419-428. PubMed ID: 28833467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left-hemispheric predominance of nigrostriatal deficit in isolated REM sleep behavior disorder.
    Iranzo A; Stefani A; Niñerola-Baizan A; Stokner H; Serradell M; Vilas D; Holzknecht E; Gaig C; Pavia J; Lomeña F; Reyes D; Seppi K; Santamaria J; Högl B; Tolosa E; Poewe W;
    Neurology; 2020 Apr; 94(15):e1605-e1613. PubMed ID: 32161031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An FP-CIT PET comparison of the difference in dopaminergic neuronal loss in subtypes of early Parkinson's disease.
    Song IU; Chung YA; Oh JK; Chung SW
    Acta Radiol; 2014 Apr; 55(3):366-71. PubMed ID: 23943629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients.
    Rossi C; Genovesi D; Marzullo P; Giorgetti A; Filidei E; Corsini GU; Bonuccelli U; Ceravolo R
    Clin Neuropharmacol; 2017; 40(1):34-36. PubMed ID: 27941527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Zoetmulder M; Nikolic M; Biernat H; Korbo L; Friberg L; Jennum P
    J Clin Sleep Med; 2016 Jun; 12(6):895-903. PubMed ID: 27070245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal dopamine transporter degeneration in right-handed REM sleep behavior disorder patients progresses faster in the left hemisphere.
    Miyamoto T; Akaiwa Y; Numahata K; Yoshizawa K; Sairenchi T; Miyamoto M
    Parkinsonism Relat Disord; 2022 Feb; 95():107-112. PubMed ID: 35093712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
    Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
    Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
    Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
    J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease.
    Spiegel J; Hellwig D; Samnick S; Jost W; Möllers MO; Fassbender K; Kirsch CM; Dillmann U
    J Neural Transm (Vienna); 2007 Mar; 114(3):331-5. PubMed ID: 16715205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
    Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
    Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder.
    Kim YK; Yoon IY; Kim JM; Jeong SH; Kim KW; Shin YK; Kim BS; Kim SE
    Eur J Neurol; 2010 Mar; 17(3):487-92. PubMed ID: 19968708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
    Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
    Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Substantia Nigra Hyperintensity at 3.0-T MR Imaging in Idiopathic REM Sleep Behavior Disorder: Comparison with
    Bae YJ; Kim JM; Kim KJ; Kim E; Park HS; Kang SY; Yoon IY; Lee JY; Jeon B; Kim SE
    Radiology; 2018 Apr; 287(1):285-293. PubMed ID: 29232183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.